Universitätsklinikum Frankfurt am Main (KGU)

Immunomodulatory and cardio-protective effects of differentially originated multipotent mesenchymal stroma cells during polymicrobial sepsis in mice (2025) Kanewska A, Lackner I, Friedrich A, Winkelmann M, Rojewski M, Weber B, Preßmar J, et al. Journal article DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms (2025) Schmitt M, Bohnenberger H, Bartsch DK, Wagner DC, Litmeyer AS, Grass A, Rinke A, et al. Journal article AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment (2025) Lorenz NI, Sauer B, Urban H, Weinem JB, Parmar BS, Zeiner PS, Strecker MI, et al. Journal article AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025 (2025) Reimer T, Kuehn T, Mueller V, Ditsch N, Fehm T, Albert US, Bartsch R, et al. Journal article, Review article First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms (2025) Thomas S, Wermke M, Vučinić V, Wagner-Drouet E, Mackensen A, Zeiser R, Bug G, et al. Journal article Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study (2025) Jaeger A, Hampl M, Prieske K, Eulenburg C, Reichenbach J, Klapdor R, Heublein S, et al. Journal article Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGEC (2025) Gomez-Iturriaga A, Tselis N, Willisch P, Guix B, Buchser D, Chyrek A, Monge RM, et al. Journal article, Review article Pharmazeutisches Entlassmanagement für Krankenhausapotheker*innen (2025) Richling I, Berger S, Britz H, Brünn R, Griese-Mammen N, Kirschke S, Kriegisch-Stumpf A, et al. Journal article Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma. (2025) DeTemple VK, Kaatz M, Stockfleth E, Scheel C, Angela Y, Gutzmer R, Leiter U, et al. Journal article ACO/ARO/AIO-22 – External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group (2025) Dapper H, Fleischmann M, Tselis N, Diefenhardt M, Hofheinz RD, Weiß C, Grabenbauer GG, et al. Journal article